BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32159729)

  • 21. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
    Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
    Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Narrowband UV-B With Psoralen-UV-A Phototherapy for Patients With Early-Stage Mycosis Fungoides: A Systematic Review and Meta-analysis.
    Phan K; Ramachandran V; Fassihi H; Sebaratnam DF
    JAMA Dermatol; 2019 Mar; 155(3):335-341. PubMed ID: 30698622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of homocysteine, folate and vitamin B12 in patients with vitiligo before and after treatment with narrow band ultraviolet B phototherapy and in a group of controls.
    Ataş H; Cemil BÇ; Gönül M; Baştürk E; Çiçek E
    J Photochem Photobiol B; 2015 Jul; 148():174-180. PubMed ID: 25941975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surrounding Needling and Narrowband Ultraviolet B Phototherapy Treatment: Synergistic Effects for Repigmentation in Chronic, Stable Nonsegmental Vitiligo.
    Chu GY; Weng SM; Huang CC; Liang WC; Hsu CH
    Altern Ther Health Med; 2023 Jan; 29(1):96-103. PubMed ID: 35212646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
    Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
    J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
    Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
    Yang YS; Cho HR; Ryou JH; Lee MH
    Int J Dermatol; 2010 Mar; 49(3):317-23. PubMed ID: 20465673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of UVB irradiance on vitiligo phototherapy and UVB-induced photocarcinogenesis.
    Yang TT; Chiu SH; Lan CE
    Photodermatol Photoimmunol Photomed; 2020 Jul; 36(4):257-262. PubMed ID: 32022939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy.
    Dong BQ; Liao ZK; Le Y; Jiang S; Luo LF; Miao F; Le Poole IC; Lei TC
    Mech Ageing Dev; 2023 Apr; 211():111779. PubMed ID: 36731753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review.
    Sokolova A; Lee A; D Smith S
    Am J Clin Dermatol; 2015 Dec; 16(6):501-31. PubMed ID: 26369540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
    Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
    J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients.
    Percivalle S; Piccino R; Caccialanza M; Forti S
    G Ital Dermatol Venereol; 2008 Feb; 143(1):9-14. PubMed ID: 18833047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
    Ortiz-Salvador JM; Ferrer DS; Saneleuterio-Temporal M; Victoria Martínez AM; Ferriols AP; Vilata Corell JJ; Alegre de Miquel V
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo.
    Kishan Kumar YH; Rao GR; Gopal KV; Shanti G; Rao KV
    Indian J Dermatol Venereol Leprol; 2009; 75(2):162-6. PubMed ID: 19293504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 308-nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: A population-based retrospective cohort study.
    Bae JM; Eun SH; Oh SH; Shin JH; Kang HY; Kim KH; Lee SC; Choi CW
    Pigment Cell Melanoma Res; 2019 Sep; 32(5):714-718. PubMed ID: 30849210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatoscopic evaluation of treatment response in patients undergoing NBUVB phototherapy for the treatment of non-segmental vitiligo: A prospective study.
    Nayak D; Vinay K; Dev A; Bishnoi A; Kumaran MS; Parsad D
    Photodermatol Photoimmunol Photomed; 2023 May; 39(3):279-281. PubMed ID: 35953438
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of tretinoin 0.05% cream to prevent hyperpigmentation during narrowband UV-B phototherapy in patients with facial vitiligo: a randomized clinical trial.
    Ju HJ; Kim SH; Lee JH; Kim GM; Bae JM
    J Dermatolog Treat; 2022 May; 33(3):1738-1741. PubMed ID: 32869680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of combination NSAID and NBUVB treatment in non-photoadapters-A pilot study.
    Mehta C; Mohammad T; Mehta D; Griffith J; Nicholson C; Hamzavi I
    Photodermatol Photoimmunol Photomed; 2019 Sep; 35(5):318-321. PubMed ID: 31004553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Keratoacanthoma in vitiligo lesion after UVB narrowband phototherapy.
    Brazzelli V; Barbagallo T; Prestinari F; Vassallo C; Agozzino M; Vailati F; Cespa M; Borroni G
    Photodermatol Photoimmunol Photomed; 2006 Aug; 22(4):211-3. PubMed ID: 16869872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.